Cargando…
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the us...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746352/ https://www.ncbi.nlm.nih.gov/pubmed/31525211 http://dx.doi.org/10.1371/journal.pone.0220977 |
_version_ | 1783451691563089920 |
---|---|
author | Djigo, Oum kelthoum Mamadou Bollahi, Mohamed Abdallahi Hasni Ebou, Moina Ould Ahmedou Salem, Mohamed Salem Tahar, Rachida Bogreau, Hervé Basco, Leonardo Ould Mohamed Salem Boukhary, Ali |
author_facet | Djigo, Oum kelthoum Mamadou Bollahi, Mohamed Abdallahi Hasni Ebou, Moina Ould Ahmedou Salem, Mohamed Salem Tahar, Rachida Bogreau, Hervé Basco, Leonardo Ould Mohamed Salem Boukhary, Ali |
author_sort | Djigo, Oum kelthoum Mamadou |
collection | PubMed |
description | BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivax endemic area in Mauritania. METHODOLOGY/PRINCIPAL FINDINGS: Venous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants were investigated using DiaPlexC G6PD genotyping kit that detects African (A(-)) and Mediterranean (B(-)) variants. Overall, 50 of 443 (11.3%) individuals (49 [11.8%] men and 1 [3.7%] woman) were phenotypically deficient. Amongst men, Black Africans had the highest prevalence of G6PD deficiency (15 of 100 [15%]) and White Moors the lowest (10 of 168, [5.9%]). The most commonly observed G6PD allelic variants among 44 tested G6PD-deficient men were the African variant A(-) (202A/376G) in 14 (31.8%), the Mediterranean variant B(-) (563T) in 13 (29.5%), and the Betica-Selma A(-) (376G/968C) allelic variant in 6 (13.6%). The Santamaria A(-) variant (376G/542T) and A variant (376G) were observed in only one and two individuals, respectively. None of the expected variants was observed in 8 (18.2%) of the tested phenotypically G6PD-deficient men. CONCLUSION: This is the first published data on G6PD deficiency in Mauritanians. The prevalence of phenotypic G6PD deficiency was relatively high (11.3%). It was mostly associated with either African or Mediterranean variants, in agreement with diverse Arab and Black African origins of the Mauritanian population. |
format | Online Article Text |
id | pubmed-6746352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-67463522019-09-27 Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania Djigo, Oum kelthoum Mamadou Bollahi, Mohamed Abdallahi Hasni Ebou, Moina Ould Ahmedou Salem, Mohamed Salem Tahar, Rachida Bogreau, Hervé Basco, Leonardo Ould Mohamed Salem Boukhary, Ali PLoS One Research Article BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivax endemic area in Mauritania. METHODOLOGY/PRINCIPAL FINDINGS: Venous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants were investigated using DiaPlexC G6PD genotyping kit that detects African (A(-)) and Mediterranean (B(-)) variants. Overall, 50 of 443 (11.3%) individuals (49 [11.8%] men and 1 [3.7%] woman) were phenotypically deficient. Amongst men, Black Africans had the highest prevalence of G6PD deficiency (15 of 100 [15%]) and White Moors the lowest (10 of 168, [5.9%]). The most commonly observed G6PD allelic variants among 44 tested G6PD-deficient men were the African variant A(-) (202A/376G) in 14 (31.8%), the Mediterranean variant B(-) (563T) in 13 (29.5%), and the Betica-Selma A(-) (376G/968C) allelic variant in 6 (13.6%). The Santamaria A(-) variant (376G/542T) and A variant (376G) were observed in only one and two individuals, respectively. None of the expected variants was observed in 8 (18.2%) of the tested phenotypically G6PD-deficient men. CONCLUSION: This is the first published data on G6PD deficiency in Mauritanians. The prevalence of phenotypic G6PD deficiency was relatively high (11.3%). It was mostly associated with either African or Mediterranean variants, in agreement with diverse Arab and Black African origins of the Mauritanian population. Public Library of Science 2019-09-16 /pmc/articles/PMC6746352/ /pubmed/31525211 http://dx.doi.org/10.1371/journal.pone.0220977 Text en © 2019 Djigo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Djigo, Oum kelthoum Mamadou Bollahi, Mohamed Abdallahi Hasni Ebou, Moina Ould Ahmedou Salem, Mohamed Salem Tahar, Rachida Bogreau, Hervé Basco, Leonardo Ould Mohamed Salem Boukhary, Ali Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania |
title | Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania |
title_full | Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania |
title_fullStr | Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania |
title_full_unstemmed | Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania |
title_short | Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania |
title_sort | assessment of glucose-6-phosphate dehydrogenase activity using carestart g6pd rapid diagnostic test and associated genetic variants in plasmodium vivax malaria endemic setting in mauritania |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746352/ https://www.ncbi.nlm.nih.gov/pubmed/31525211 http://dx.doi.org/10.1371/journal.pone.0220977 |
work_keys_str_mv | AT djigooumkelthoummamadou assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT bollahimohamedabdallahi assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT hasnieboumoina assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT ouldahmedousalemmohamedsalem assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT taharrachida assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT bogreauherve assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT bascoleonardo assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania AT ouldmohamedsalemboukharyali assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania |